cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation

Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1982-8. doi: 10.1152/ajpheart.2000.279.4.H1982.

Abstract

Nitric oxide (NO) has concentration-dependent biphasic myocardial contractile effects. We tested the hypothesis, in isolated rat hearts, that NO cardiostimulation is primarily non-cGMP dependent. Infusion of 3-morpholinosydnonimine (SIN-1, 10(-5) M), which may participate in S-nitrosylation (S-NO) via peroxynitrite formation, increased the rate of left ventricular pressure rise (+dP/dt; 19 +/- 4%, P < 0.001, n = 11) without increasing effluent cGMP or cAMP. Superoxide dismutase (SOD; 150 U/ml) blocked SIN-1 cardiostimulation and led to cGMP elaboration. Sodium nitroprusside (10(-10)-10(-7) M), an iron nitrosyl compound, did not augment +dP/dt but increased cGMP approximately eightfold (P < 0.001), whereas diethylamine/NO (DEA/NO; 10(-7) M), a spontaneous NO. donor, increased +dP/dt (5 +/- 2%, P < 0.05, n = 6) without augmenting cGMP. SIN-1 and DEA/NO +dP/dt increase persisted despite guanylyl cyclase inhibition with 1H-(1,2,4)oxadiazolo-(4,3,-a)quinoxalin-1-one (10(-5) M, P < 0.05 for both donors), suggesting a cGMP-independent mechanism. Glutathione (5 x 10(-4) M, n = 15) prevented SIN-1 cardiostimulation, suggesting S-NO formation. SIN-1 also produced SOD-inhibitable cardiostimulation in vivo in mice. Thus peroxynitrite and NO donors can stimulate myocardial contractility independently of guanylyl cyclase activation, suggesting a role for S-NO reactions in NO/peroxynitrite-positive inotropic effects in intact hearts.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cyclic GMP / metabolism
  • Cyclic GMP / physiology*
  • Diethylamines / pharmacology
  • Drug Combinations
  • Enzyme Inhibitors / pharmacology
  • Glutathione / pharmacology
  • In Vitro Techniques
  • Male
  • Molsidomine / analogs & derivatives*
  • Molsidomine / antagonists & inhibitors
  • Molsidomine / pharmacology
  • Myocardial Contraction / drug effects*
  • Nitrates / pharmacology*
  • Nitric Oxide / metabolism*
  • Nitric Oxide / pharmacology
  • Nitric Oxide Donors / pharmacology*
  • Nitroprusside / pharmacology
  • Nucleotides, Cyclic / metabolism
  • Oxadiazoles / pharmacology
  • Oxidation-Reduction
  • Quinoxalines / pharmacology
  • Rats
  • Rats, Wistar
  • Superoxide Dismutase / pharmacology

Substances

  • 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one
  • Diethylamines
  • Drug Combinations
  • Enzyme Inhibitors
  • Nitrates
  • Nitric Oxide Donors
  • Nucleotides, Cyclic
  • Oxadiazoles
  • Quinoxalines
  • Nitroprusside
  • peroxynitric acid
  • Nitric Oxide
  • linsidomine
  • diethylamine
  • Molsidomine
  • Superoxide Dismutase
  • Glutathione
  • Cyclic GMP